APRICUS BIOSCIENCES, INC. Business Finance Contracts & Agreements

120 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Form of Placement Agent Warrant
Warrant Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
2024
Form of New Warrant
Warrant Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
2024
Amendment No. 7 to Convertible Promissory Note, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC, effective June 1, 2024
Note Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2024
Amendment No. 6 to Convertible Promissory Note, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC, effective May 1, 2024
Note Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2024
Amendment No. 5 to Convertible Promissory Note, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC, effective March 27, 2024
Note Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2024
Form of Securities Purchase Agreement, dated January 26, 2024
Purchase Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2024
Form of Common Warrant
Warrant Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
2024
Form of Common Warrant
Warrant Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2023
Form of Pre-Funded Warrant
Warrant Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
2023
Underwriting Agreement, dated as of November 28, 2023, by and between Seelos Therapeutics, Inc. and Titan Partners Group, LLC
Underwriting Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2023
Amendment No. 4 to Convertible Promissory Note and Amendment to Letter Agreement, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC, effective...
Note Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2023
Form of Securities Purchase Agreement, dated September 21, 2023
Purchase Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2023
Form of Warrant
Warrant Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2023
Form of Amendment No. 1 to Securities Purchase Agreement, by and between Seelos Therapeutics, Inc. and each purchaser identified on the signature pages thereto, dated May 19, 2023
Purchase Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2023
Form of Warrant, dated May 19, 2023
Warrant Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2023
Amendment No. 3 to Convertible Promissory Note, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC, dated May 19, 2023
Note Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2023
Form of Securities Purchase Agreement, dated March 10, 2023
Purchase Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2023
Form of Common Warrant
Warrant Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2023
Form of Pre-Funded Warrant
Warrant Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2023
Amendment No. 2 to Convertible Promissory Note, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC, dated February 8, 2023
Note Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2023
Amendment No. 5 to Asset Purchase Agreement, dated April 8, 2022, by and between Seelos Corporation and Phoenixus AG
Purchase Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2022
Amendment to Convertible Promissory Note, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC, dated December 10, 2021
Note Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2022
Common Stock Purchase Agreement, dated as of November 24, 2021, by and between Seelos Therapeutics, Inc. and iX Biopharma Europe Limited
Stock Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2021
Security Agreement, dated as of November 23, 2021, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC
Security Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2021
Securities Purchase Agreement, dated as of November 23, 2021, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management V, LLC
Purchase Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2021
Form of Convertible Promissory Note due November 23, 2024
Note Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2021
Underwriting Agreement, dated as of May 20, 2021, by and between Seelos Therapeutics, Inc. and Guggenheim Securities, LLC
Underwriting Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2021
Amendment No. 4 to Asset Purchase Agreement, dated February 15, 2021, by and between Seelos Corporation and Phoenixus AG
Purchase Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2021
Underwriting Agreement, dated as of January 25, 2021, by and between Seelos Therapeutics, Inc. and BTIG, LLC
Underwriting Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2021
Security Agreement, dated as of December 11, 2020, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management II, LLC
Security Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2020
Securities Purchase Agreement, dated as of December 11, 2020, by and between Seelos Therapeutics, Inc. and Lind Global Asset Management II, LLC
Purchase Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2020
Form of Convertible Promissory Note due December 11, 2022
Note Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2020
Securities Purchase Agreement, dated September 4, 2020
Purchase Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2020
Form of Warrant
Warrant Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
2020
Underwriting Agreement, dated as of March 11, 2020, by and between Seelos Therapeutics, Inc. and The Benchmark Company, LLC, as representative of the underwriters named therein
Underwriting Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2020
Underwriting Agreement, dated as of February 10, 2020, by and between Seelos Therapeutics, Inc. and The Benchmark Company, LLC, as representative of the underwriters named therein
Underwriting Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2020
Form of Underwriting Agreement
Underwriting Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2020
Stock Purchase Agreement, dated as of January 2, 2020, by and between Seelos Therapeutics, Inc. and Phoenixus AG
Stock Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2020
Amendment No. 2 to Asset Purchase Agreement, dated as of December 31, 2018, by and between Seelos Therapeutics, Inc. and Phoenixus AG f/k/a Vyera Pharmaceuticals AG and Turing...
Purchase Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2019
Amendment No. 3 to Asset Purchase Agreement, dated October 15, 2019, by and between Seelos Therapeutics, Inc. and Phoenixus AG
Purchase Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NV
2019